SCHEMBL10696964

SCHEMBL10696964

CN1CCc2cccc(Br)c2CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 2/20 0.61
ADRA2B P18089 2/20 0.61
ADRA2C P18825 2/20 0.61
CYP2D6 P10635 1/20 0.61
ADRA1D P25100 1/20 0.61
ADRA1A P35348 1/20 0.61
ADRA1B P35368 1/20 0.61
NPSR1 Q6W5P4 1/20 0.59
DRD2 P14416 3/20 0.50
DRD1 P21728 3/20 0.50
DRD5 P21918 3/20 0.50
DRD3 P35462 3/20 0.50
MAOA P21397 2/20 0.50
MAOB P27338 2/20 0.50
DRD4 P21917 1/20 0.50
CARM1 Q86X55 2/20 0.44
PRMT6 Q96LA8 1/20 0.44
PRMT1 Q99873 1/20 0.44
SETD7 Q8WTS6 1/20 0.43
ABHD6 Q9BV23 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10990863 0.98 NPSR1 (0.62) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL16076617 0.89 MAOA (0.57) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL3117967 0.89 MAOA (0.57) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL10604288 0.80 S1PR5 (0.49) DRD2DRD3DRD4CARM1PRMT6
SCHEMBL3976079 0.78
SCHEMBL25815860 0.78 CARM1 (0.51) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL8083358 0.76 ADRA2A (1.00) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL19599365 0.76 DRD2 (0.74) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL7792059 0.76 ADRA2C (0.61) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL10605050 0.76 ADRA2A (0.61) ADRA2AADRA2BADRA2CCYP2D6ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0278165-A2 Use of 3-benzazepines in the treatment of benign prostatic hypertrophy SMITHKLINE BEECHAM CORPORATION (US) 1988-08-17 EP claimed
US-4469634-A Allyloxy- and allylthio-2,3,4,5-tetrahydro-1H-3-benzazepines SMITHKLINE BECKMAN CORPORATION (US) 1984-09-04 US disclosed
EP-0103961-A1 Allyloxy- and allylthio-2,3,4,5-tetrahydro-1H-3-benzazepines SMITHKLINE BECKMAN CORPORATION (US) 1984-03-28 EP disclosed
EP-0080012-A1 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate SMITHKLINE BECKMAN CORPORATION (US) 1983-06-01 EP disclosed
EP-0007070-B1 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY SMITHKLINE BECKMAN CORPORATION (US) 1983-01-19 EP disclosed
US-4265890-A ANTIPSYCHOTIC, ANTIEMETICS SMITHKLINE CORPORATION (US) 1981-05-05 US disclosed
EP-0007070-A1 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity SMITHKLINE BECKMAN CORPORATION (US) 1980-01-23 EP disclosed